Vibalogics

Vibalogics (now part of Recipharm) is a full-service CDMO offering process technical transfer, development, GMP manufacturing, testing and fill-finish services to innovators developing virotherapies. Through a comprehensive set of clinical- and commercial-enabling service offerings, we partner with our clients to support early-to-late stage success. Built on a foundation of robust industry-leading scientific expertise, quality systems and global regulatory compliance, we deliver manufactured products with a complementing customer service experience that is customer friendly, communication-forward, transparent and flexible. Service Offerings: GMP Cell Banking | GMP Viral Banking | Technical Transfer | Process & Analytical Development | GMP Drug Substance Manufacture | GMP Drug Product Manufacture | Formulation, Fill & Finish | Lot / Batch Release | Stability Studies Product Experience Includes: Live Viruses | Viral Vectors | Oncolytic Viruses | Gene Therapy | Vaccines | Adenovirus (Primate & Human) | Adeno-Associated (AAV) | Dengue | Herpes (HSV, Marek Disease, CMV) | Influenza (Flu) | Infectious Bursal Disease (IBDV) | Measles (Rubeola) | Newcastle Disease (NDV) | Poxviruses | Porcine Reproductive Respiratory Syndrome (PRRSV) | Respiratory-Syncitial Virus (RSV) | Vaccinia (VACV/MVA) | Vesicular Stomatitis Virus (VSV)

Industry

Biotechnology Research

Company size

201-500 employees

Headquarters

Boxborough, Massachusetts

Type

Privately Held

Specialties

GMP Manufacturing, Process Development, Analytical Method Development, Technical Transfer, GMP Cell Banking, GMP Viral Banking, GMP Fill & Finish, Stability Studies, Oncolytic Viruses, Viral Vaccines, Viral Vectors, Gene Therapies, Vaccinia, MVA, Adenovirus, HSV, and VSV